![Frontiers | Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data Frontiers | Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data](https://www.frontiersin.org/files/Articles/720649/fcell-09-720649-HTML/image_m/fcell-09-720649-g002.jpg)
Frontiers | Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data
![Evaluation of two strategies for the interpretation of tumour markers in pleural effusions | Respiratory Research | Full Text Evaluation of two strategies for the interpretation of tumour markers in pleural effusions | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-017-0582-1/MediaObjects/12931_2017_582_Fig2_HTML.gif)
Evaluation of two strategies for the interpretation of tumour markers in pleural effusions | Respiratory Research | Full Text
![Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.11.32/asset/images/medium/figure1.gif)
Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology
Cheng Jian Biomedical - How to detect cancer cell? Tumor Markers In healthy asymptomatic individuals, biomarkers (tumor markers)may be used in the identification of those at increased risk of developing malignancy and
Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective - Cutaneous Melanoma - NCBI Bookshelf
![Cancers | Free Full-Text | Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application Cancers | Free Full-Text | Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application](https://www.mdpi.com/cancers/cancers-02-00523/article_deploy/html/images/cancers-02-00523-g003.png)
Cancers | Free Full-Text | Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application
A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts | PLOS ONE
![Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications: 9781890883713: Medicine & Health Science Books @ Amazon.com Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications: 9781890883713: Medicine & Health Science Books @ Amazon.com](https://m.media-amazon.com/images/I/A1pYu6qtZkL._AC_UF1000,1000_QL80_.jpg)
Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications: 9781890883713: Medicine & Health Science Books @ Amazon.com
![The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis: Molecular Therapy - Nucleic Acids The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/3ac33437-8a33-4584-b953-79ddc3169c3c/fx1_lrg.jpg)
The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis: Molecular Therapy - Nucleic Acids
![Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites | Anticancer Research Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/35/10/5655/F1.large.jpg)
Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites | Anticancer Research
![Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine](https://www.thelancet.com/cms/attachment/1627be14-a160-49b1-87a4-c9d7e0061887/gr1_lrg.jpg)